Preferential attack on cancer following major cancer surgery.
D000362:Agar; D000477:Alkylating Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000378:metabolism; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D008466:Mechlorethamine / Q000494:pharmacology; D008722:Methods; D008727:Methotrexate / Q000494:pharmacology; D009369:Neoplasms / Q000378:metabolism / Q000601:surgery*; D009360:Neoplastic Cells, Circulating / Q000188:drug therapy; D011868:Radioisotopes; D013438:Sulfhydryl Compounds / Q000037:antagonists & inhibitors
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011868:Radioisotopes; D013438:Sulfhydryl Compounds; D008466:Mechlorethamine; D000362:Agar; D005472:Fluorouracil; D008727:Methotrexate